US Broker Ratings

Xencor, Inc. (XNCR) Stock Analysis: Exploring an 84% Potential Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector would do well to keep an eye on Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company based in Pasadena, California. With..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a Potential 171% Upside in Telehealth

LifeMD, Inc. (NASDAQ: LFMD), a prominent player in the burgeoning telehealth industry, is currently trading at a price of $3.41, with a market capitalization of approximately $164.14 million. Despite a..

KalVista Pharmaceuticals (KALV) Stock Analysis: A Biotech Contender with a 91.95% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology sector, has been making waves with its promising therapeutic candidates. Based in Cambridge, Massachusetts, this biopharmaceutical company focuses on..

Day One Biopharmaceuticals (DAWN) Stock Analysis: Uncovering a 138% Potential Upside in the Biotechnology Sector

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) has emerged as a noteworthy player in the biotechnology industry, capturing investor attention with a compelling potential upside of 138.73%. This commercial-stage company is..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating a 5.75% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB) is a notable player in the healthcare sector, specifically within the medical care facilities industry. Based in Dallas, Texas, Enhabit specializes in providing home health and..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Exploring the 185.61% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR) stands out in the biotechnology sector, primarily due to its ambitious approach to combating serious infectious diseases through a robust pipeline of investigational therapies. With..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: 65.71% Upside Potential Draws Investor Attention

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, is catching the eyes of investors with its promising pipeline and substantial upside potential. As the company focuses on developing novel..

Immunome, Inc. (IMNM) Stock Analysis: Evaluating the 59% Potential Upside in Biotech Innovation

Immunome, Inc. (NASDAQ: IMNM), a trailblazer in the biotechnology sector, is capturing investor attention with its promising portfolio of targeted cancer therapies. As a clinical-stage company dedicated to the development..

Zevra Therapeutics, Inc. (ZVRA): Investor Outlook with a 151.6% Potential Upside

Investors seeking high-growth opportunities in the biotechnology sector should take a closer look at Zevra Therapeutics, Inc. (NASDAQ: ZVRA). With a focus on addressing unmet medical needs in rare diseases,..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 126.63% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands as a beacon of innovation in the biotechnology sector, focusing on the development of gene therapies for rare and life-threatening diseases. With a market..

Talkspace, Inc. (TALK) Stock Analysis: Potential 33.81% Upside as Digital Healthcare Expands

Talkspace, Inc. (NASDAQ: TALK) is making waves in the rapidly growing digital healthcare sector. As a virtual behavioral healthcare company, Talkspace connects patients with licensed mental health providers via an..

Investor Outlook: Amylyx Pharmaceuticals (AMLX) Offers 67.4% Upside Potential Amid Strong Buy Ratings

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Based in Cambridge, Massachusetts, this clinical-stage pharmaceutical..

Savara, Inc. (SVRA) Stock Analysis: Biotech’s 79% Potential Upside Ignites Investor Interest

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is captivating investor attention with its impressive potential upside. Specializing in rare respiratory diseases, Savara’s valuation and market positioning present a compelling..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Contender with a 49.77% Upside Potential

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to developing small molecule and antibody therapies. With a market capitalization..

AbCellera Biologics Inc. (ABCL): Investor Outlook with a Robust 187.52% Potential Upside

AbCellera Biologics Inc. (ABCL), a Canadian biotechnology firm, is capturing the attention of investors given its substantial potential upside of 187.52%. Situated in the burgeoning healthcare sector, AbCellera is making..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unpacking the 1,704.70% Revenue Growth and 25.56% Potential Upside

In the ever-evolving landscape of biotechnology, Nuvation Bio Inc. (NUVB) stands out as an intriguing player, particularly for those investors seeking exposure to the healthcare sector. With a market capitalization..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Exploring a 15% Upside Potential and Robust Revenue Growth

Phibro Animal Health Corporation (NASDAQ: PAHC) stands as a noteworthy name in the healthcare sector, specifically within the drug manufacturers category. As an established entity with a market capitalization of..

Valneva SE (VALN) Stock Analysis: Exploring a 46.12% Potential Upside in the Biotech Sector

Valneva SE (VALN), a prominent player in the biotechnology sector, is capturing investor attention with its promising innovations in vaccine development. Based in Saint-Herblain, France, Valneva specializes in developing vaccines..

uniQure N.V. (QURE) Stock Analysis: Unveiling a 131% Potential Upside in the Biotech Sector

Investors eyeing the dynamic biotechnology sector should not overlook uniQure N.V. (QURE), a Netherlands-based innovator in gene therapy. With its current stock price at $23.93, uniQure presents an intriguing opportunity,..

Butterfly Network, Inc. (BFLY) Investor Outlook: Exploring a 10.20% Upside Potential with Strong Buy Ratings

Butterfly Network, Inc. (NASDAQ: BFLY), a company at the forefront of medical imaging technology, is drawing attention from investors with its innovative ultrasound solutions. Based in Burlington, Massachusetts, Butterfly Network..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds